Filter posts

Life Science Leader on TransCelerate’s Efforts to Modernize Drug Development

Life Science Leader’s Rob Wright has a great profile on TransCelerate BioPharma and their efforts …

2013 Novel Drug Approvals

The FDA approved 24 novel drugs last year by our count, in line with average …

BIO Submits Comments to the EPA’s 2014 RVO Proposed Rule

The public comment period for the Environmental Protection Agency’s (EPA) 2014 proposal on the Renewable …

IPAB: Bad Medicine for Patient Care

The Independent Payment Advisory Board is bad medicine for patient care, deficit reduction and containing …

Triumph of the anti-GMO movement would be a disaster

In Discover magazine’s Collide-a-Scape blog, Keith Kloor writes about Why GMOs Matter. Kloor reflects on …

More than a Quarter of 2013 US-Based Biotech IPOs Call California Home

And of those 39 US-based biotech companies, five of them are from San Diego, highlighting …

NPR’s Shots Blog: Vaccine Fears Fueled The Resurgence Of Preventable Diseases

This past weekend, Michaeleen Doucleff at NPR’s Shots blog shared a fascinating but disturbing map …

Stable Policy Can Help Assure Unwavering Investment in U.S. Biofuels

The Renewable Fuel Standard (RFS) is a unique federal policy that has, just as its …

BIO CEO Company Snapshot: Conatus Pharmaceuticals

The Company Snapshots have returned for our next One-on-One Partnering event, the BIO CEO & …

The Hill's Congress Blog: Innovation in medicine isn't optional - it's imperative

Earlier this week, The Hill’s Congress Blog posted an op-ed penned by Andrew von Eschenbach …